NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-103-2005-3-AU-04 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies AU National Stage 2006210792 Issued
NIMH E-043-1997-2-US-03 Methods for Expression and Purification of Immunotoxins US National Stage 10/566,886 7892786 Expired PDF
NCI E-104-2005-1-PCT-02 Furin Inhibitors For Prevention Of Papillomarvirus Infection PCT PCT PCT/US2006/003844 Abandoned
NCI E-103-2005-3-PCT-01 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies PCT PCT COMB PCT/US2006/003601 Expired
NCI E-064-2005-0-EP-05 Biomarkers For Tissue Status EP National Stage 06734182.6 Abandoned
NCI E-064-2005-0-PCT-02 Biomarkers For Tissue Status PCT PCT PCT/US06/003611 Expired
NCI E-064-2005-0-AU-03 Biomarkers For Tissue Status AU National Stage 2006210794 Abandoned
NCI E-064-2005-0-CA-04 Biomarkers For Tissue Status CA National Stage 2596469 Abandoned
NIAID E-145-2004-1-US-01 Monoclonal Antibodies Against Orthopoxviruses US 60/763,786 Abandoned
NHGRI E-055-2005-2-EP-03 Farnesyltransferase Inhibitors (FTIs) For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis EP National Stage 06733984.6 Abandoned
NHGRI E-055-2005-2-GB-10 Farnesyltransferase Inhibitors (FTIs) For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis GB EP 06733984.6 Abandoned
NHGRI E-055-2005-2-DE-08 Farnesyltransferase Inhibitors (FTIs) For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis DE EP 06733984.6 Abandoned
NHGRI E-055-2005-2-FR-09 Farnesyltransferase Inhibitors (FTIs) For Treatment of Laminopathies, Cellular Aging, And Artherosclerosis FR EP 06733984.6 Abandoned
NHGRI E-055-2005-2-PCT-01 Methods And Use Of Farnesyl Transferase Inhibitors (FTIs) For Laminopathies, Cellular Aging, And Artherosclerosis PCT PCT COMB PCT/US2006/002977 Expired
NIAID E-270-2004-0-CZ-09 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY CZ EP 06733918.4 Issued
NIAID E-270-2004-0-IT-14 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY IT EP 06733918.4 Issued
NIAID E-270-2004-0-FR-12 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY FR EP 06733918.4 Issued
NIAID E-270-2004-0-DE-10 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY DE EP 06733918.4 Issued
NIAID E-270-2004-0-CH-08 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY CH EP 06733918.4 Issued
NIAID E-270-2004-0-GB-13 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY GB EP 06733918.4 Issued
NIAID E-270-2004-0-EP-05 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY EP National Stage 06733918.4 Issued
NIAID E-270-2004-0-AT-07 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY AT EP 06733918.4 Issued
NIAID E-270-2004-0-ES-11 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY ES EP 06733918.4 Issued
NIAID E-270-2004-0-SE-15 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY SE EP 06733918.4 Issued
NIAID E-270-2004-0-CA-06 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY CA National Stage 2641221 Issued
NIAID E-270-2004-0-PCT-03 METHOD TO PREDICT AND PREVENT OXYGEN-INDUCED INFLAMMATORY TISSUE INJURY PCT PCT PCT/US2006/002765 Expired
NIDDK E-091-2006-0-US-01 A3 Adenosine Receptor Allosteric Modulators US 60/762,141 Abandoned
NIAID E-270-2004-0-US-02 Oxygenation Inhibits The Phsiological Tissue-protecting Mechanism And Thereby Exacerbates Acute Inflammatory Lung Injury US National Stage 11/339,208 8455437 Issued PDF
NINDS E-082-1997-1-US-02 USE OF MARROW-DERIVED GLIAL PROGENITORS CELLS AS GENE DELIVERY VECHICLES INTO THE CENTRAL NERVOUS SYSTEM US DIV 11/340,322 Abandoned
NICHD E-181-2004-0-CA-04 NANDROLONE 17 BETA-CARBONATES CA National Stage 2596884 Abandoned
NICHD E-181-2004-0-JP-06 NANDROLONE 17 BETA-CARBONATES JP National Stage 554134/2007 Abandoned
NICHD E-181-2004-0-AU-03 NANDROLONE 17 BETA-CARBONATES AU National Stage 2006211907 Abandoned
NICHD E-181-2004-0-GB-10 NANDROLONE 17 BETA-CARBONATES GB EP 06719336.7 Abandoned
NICHD E-181-2004-0-DE-08 NANDROLONE 17 BETA-CARBONATES DE EP 06719336.7 Abandoned
NICHD E-181-2004-0-FR-09 NANDROLONE 17 BETA-CARBONATES FR EP 06719336.7 Abandoned
NICHD E-181-2004-0-EP-05 NANDROLONE 17 BETA-CARBONATES EP National Stage 06719336.7 Abandoned
NICHD E-181-2004-0-PCT-02 NANDROLONE 17B-CARBONATES PCT PCT PCT/US2006/02436 Expired
NICHD E-027-2006-0-US-01 PDE11A MUTATIONS IN ADRENAL DISEASE US 60/761,446 Abandoned
NIAID E-159-2006-2-US-02 Adenoviral Vector-based Vaccines US National Stage 11/337,866 Abandoned
NCI E-007-2004-1-US-02 Pyrrolobenzodiazepines US CON 11/336,623 Abandoned
NCI E-228-2003-2-US-03 SOLUBLE FRAGMENTS OF THE SARS-COV SPIKE GLYCOPROTEIN US ORD 11/335,197 Abandoned
NIAID E-031-2006-0-US-01 Chlamydia Vaccine US 60/760,970 Abandoned
NIAID E-317-2003-0-US-06 Accelerated Vaccination US National Stage 11/332,976 7635485 Expired PDF
NIAID E-232-2004-3-US-02 Compositions And Methods For Generating An Immune Response US CON 11/333,770 Abandoned
NIAID E-144-2004-0-PCT-02 Monoclonal Antibodies that Bind or Neutralize Hepatitis B Virus PCT PCT PCT/US2006/001336 Expired
NIAID E-144-2004-0-EP-04 Monoclonal Antibodies that Bind or Neutralize Hepatitis B Virus EP National Stage 06718415.0 Abandoned
NCI E-254-2005-0-US-01 Improved IL-15 for Expression in Mammalian Cells US 60/758,819 Abandoned
NCI E-267-2005-0-US-01 Improved IL-12 For Expression in Mammalian Cells US 60/758,680 Abandoned
NIAID E-144-2004-0-CA-03 Monoclonal Antibodies that Bind or Neutralize Hepatitis B Virus CA National Stage 2594922 Abandoned
NIAID E-295-2004-0-EP-05 Attenuated Human Parainfluenza Virus, Methods And Uses Thereof EP National Stage 06850427.3 Issued